Bodenhoff Mads
SVP & PAO
Bodenhoff Mads has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, Bodenhoff Mads is listed as SVP & PAO at Ascendis Pharma A/S. Inside the rolling window, Bodenhoff Mads reported no open-market purchases and 1 open-market sale totaling $811K in ASND.
Companies traded
Other insiders at ASND
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$811K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bodenhoff Mads made?
Bodenhoff Mads has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Bodenhoff Mads trade?
Bodenhoff Mads has filed SEC Form 4 disclosures for 1 company, including ASND.
When was Bodenhoff Mads's most recent SEC Form 4 filing?
Bodenhoff Mads's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is Bodenhoff Mads's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bodenhoff Mads is listed as SVP & PAO.
What is Bodenhoff Mads's total buy and sell value in the current window?
Inside the rolling retention window, Bodenhoff Mads bought $0 and sold $811K based on SEC Form 4 filings.
What was Bodenhoff Mads's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,000 ASND shares on 2026-09-08, worth $811K, per SEC Form 4 filings.